← All organizations

Gamida Cell

For profitContributed to NMEWebsite ↗

Also known as: GAMIDA | Gamida Cell ltd | Gamida Cell Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Sep 24, 2025

Timeline

1990s

Jun 1, 1998
Gamida Cell— Founded

2020s

Apr 17, 2023
omidubicel— NDA Organization

Drugs by trial phase (15 distinct, 10 trials)

Phase 4 (8 own, 0 via acquisition)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

omidubicel

Recent trials (12)

NCT07101445CollaboratorPhase 4Sep 24, 2025
NCT05296525Lead sponsorPhase 1/Phase 2Jul 5, 2022
NCT04260698Lead sponsorPhase 3Jun 15, 2020
NCT02730299Lead sponsorPhase 3Nov 1, 2016
NCT02504619Lead sponsorPhase 1/Phase 2May 1, 2015
NCT01816230Lead sponsorPhase 1/Phase 2Apr 1, 2013
NCT01590628Lead sponsorPhase 1/Phase 2Apr 1, 2012
NCT01590628Study directorPhase 1/Phase 2Apr 1, 2012
NCT01221857Study directorPhase 1/Phase 2Nov 1, 2010
NCT01221857Lead sponsorPhase 1/Phase 2Nov 1, 2010
NCT01484470CollaboratorPhase 2Jan 1, 2010
NCT00444262CollaboratorPhase 3Apr 1, 2007

Details

Founded: Jerusalem, IL Jun 1, 1998
First NDA: Apr 17, 2023
Last known activity: Sep 24, 2025

Designations held

Orphan drug
Breakthrough therapy